People

Mr Joseph Carrozzi, formerly Managing Partner at PWC, is an experienced board Chair and business advisor, covering major corporations, government sector and also not for profit. He recently stepped down…

Patrick Bertolino is a Faculty member at the Centenary Institute (CI) where he leads the Liver Immunology Group. He is a leader in the field within Australia, and is considered…

Research InterestsRecently, he initiated new collaborative research programs in Vietnam on improving the control of tuberculosis and on immunogenetics of tuberculosis. Achievements Since 1997 his group has used an aerosol…

Professor Jennifer Gamble is an internationally recognised research leader in the field of endothelial cell function and holds the Inaugural Wenkart Chair of the Endothelium. Her interests lie in understanding…

Upon completion of his postdoctoral training at the University of Oxford in 1986 as a CJ Martin Fellow, Geoff returned to Sydney where he developed the basic research program for…

David Bowen is Associate Faculty at the Centenary Institute, where he co-leads the Liver Immunology Program with A/Prof Patrick Bertolino. He is also an Associate Professor at the Sydney Medical…

Professor Mark Gorrell heads the Liver Enzymes in Metabolism and Inflammation Program. He trained in cell biology, virology, immunology and protein biochemistry at the Australian National University and University of…

Ms Dibbs is a non-executive director in the government and for-purpose sectors. She is the Western Parkland City Commissioner on the Greater Cities Commission, Deputy Chancellor of Western Sydney University…

After earning bachelor’s and doctoral degrees in biochemistry at Hull, Flavell did postdoctoral work in the Netherlands and Switzerland and then joined the faculty of the University of Amsterdam. From…

Professor Good is the past Chairman of the National Health and Medical Research Council, Director of the Queensland Institute of Medical Research and President of the Association of Australian Medical…

Professor Feldmann’s interests focus on molecular mechanisms of autoimmune diseases, with a special interest in the role of cytokines in disease. These interests range from gene regulation of cytokines, how…

Internationally-renowned for the co-creation of the technology for the cervical cancer vaccines, Professor Frazer began his career as a renal physician and clinical immunologist in Edinburgh, Scotland before emigrating in…

Matthias Hentze is the Director of the European Molecular Biology Laboratory (EMBL) and Co-Director of the Molecular Medicine Partnership Unit (MMPU). Following medical training in Germany and the UK, he…

Professor Ullrich is a pioneer in cancer research and is responsible for the discovery of the HER2/neu oncogene, the basis for Herceptin (Trastuzumab), the breakthrough therapeutic for breast cancer. Trastuzumab…

BE (Hons), PhD, Hon DSc (UNSW), MBA, Hon DSc (Macq), FAICD, FTSE, FIEAust (Hon) Dr Roberts is the former Chief Executive Officer of Cochlear Limited and currently a Member of…

Sydney Catalyst Chair in Translational Cancer Research Prof Philip Hogg graduated with a PhD in biochemistry from the University of Queensland in 1987. Following post-doctoral training in the USA and…

Michael Coleman is an experienced director and Chairman. He is a pragmatic risk manager and Audit Committee expert specialising in financial services, property, funds management and media.He is currently a…

Professor Stow, with a PhD from Monash University, trained at Yale University School of Medicine (USA). She was then appointed as an Assistant Professor at Massachusetts General Hospital/Harvard Medical School…

Dr Seth has a wide spectrum of expertise in molecular/cellular biology, genetics, clinical, cancer research, industrial biotechnology and corporate management. Dr Seth directs a unique Research Program in Australia addressing…

Prof Visvader carried out PhD studies in the Department of Biochemistry at the University of Adelaide, and held subsequent positions as a postdoctoral fellow at the Salk Institute, San Diego,…

Natasha Nankivell is the Managing Director and Founder at Global Alternative Funds. Ms Nankivell is also Council Member and Member of Finance and Resources Committee, University of Wollongong. Over her…

Professor Phil Hansbro is an internationally recognised research leader in the study of respiratory diseases, such as asthma, chronic obstructive airway disease (COPD, aka emphysema) and infections and is developing…

Dr Ulf Schmitz is a computational biologist with training in bioinformatics and systems biology. He completed his PhD in June 2015 at the University of Rostock (Germany) under the supervision…

Associate Professor Taylor is the Executive Director, Camperdown Health Education Research Precinct (CHERP) and Executive Director, Sydney Research for the Sydney Local Health District with over 30 years experience as a…

Paul Chadwick is a Managing Director and founder of Nanuk Asset Management, a Sydney based firm founded in late 2009 that specialises in global investments related to environmental sustainability. Previously,…

Professor Robyn Ward AM FAHMS joined the University of Sydney in July 2018 as the inaugural Executive Dean of the Faculty of Medicine and Health. She was the former Deputy…

Dr Richard Bagnall is a research leader in the study of human genetic diseases. He defined the genetic causes of the blood clotting disorder, haemophilia A, at King’s College London,…

Associate Professor Daniel Hesselson is an internationally trained research leader in regenerative medicine, focusing on cells and organs affected by heart disease, diabetes, and Parkinson’s disease. His work uses insights…

Dr Yanfei (Jacob) Qi trained in lipid metabolism and signalling in his PhD at Centenary Institute, the University of Sydney and then following Postdoctoral research at the University of NSW.…

Dr Jessamy Tiffen leads the Epigenetics of Melanoma Program at the Centenary Institute. She is an expert in the study of epigenetic regulation in cancer. She has an excellent publication…

Dr Chuck (Charles) Bailey, is the head of the Cancer and Gene Regulation Laboratory at the Centenary Institute. He trained as a molecular and cellular biologist (PhD, CRC for Biopharmaceutical…

Professor Kelly is currently the Chief Medical Officer at the Australian Government Department of Health. Prior to this appointment, he was the Acting Chief Medical Officer, leading the Government’s health…

Dr Frankcombe manages the translation and commercialisation of Centenary discoveries with the aim of delivering new diagnostics and treatments for patients. She has over 18 years of commercialisation experience, both…

Dr Begley currently advises several biotechnology companies, academic groups and served as Chief Scientific Officer at two small biotechnology companies, From 2002-2012, he was Vice-President and Global Head of Hematology/Oncology…

Jamie Nettleton is a partner in the Intellectual Property group at Addisons Lawyers in Sydney. Jamie has practised law in both Sydney and London and has advised extensively in respect…

Mr Ryan is a director and Chairman of the Investment Committee at Nanuk Asset Management and Chairman of Orion Asset Management. He founded Orion in 2002 and has over 36…

Peter Sutherland has over 30 years experience in financial services, both in Australia and overseas, principally the United Kingdom and United States. Peter has held senior risk management, compliance and…

Associate Professor Andy Philp is Head of the Biology of Ageing Program and convenor of the Centre for Healthy Ageing at the Centenary Institute. Andy is an internationally recognised expert…

Alison joined the Centenary Institute in October 2021 as the Head of Communications & Marketing. In this position she leads the development and delivery of a comprehensive strategy to elevate…

As the Head of People and Culture for Centenary, Alison is responsible for the overall strategic and operational management of People and Culture, WHS and Compliance. Alison has a background…

Professor Marc Pellegrini MB BS BSc FRACP PhD FAHMS is an infectious diseases physician, host-pathogen molecular biologist, and Executive Director at the Centenary Institute. An internationally renowned research scientist, Professor…

Dr Kearney holds an MBA from the University of Sydney and completed his PhD in the genetics at the Monash University. He spent a post-doc at Imperial College London mapping…

Guy Lyons obtained his PhD from the University of Sydney and then undertook postdoctoral training at the University of Alabama at Birmingham, USA, and Université Louis Pasteur, Strasbourg, France. He…

Bachelor of Commerce (University of Lincoln), Master of Enterprise Administration (University of Melbourne), Executive Fellow (Australia and New Zealand School of Government) and Graduate (Australian Institute of Company Directors) Sam…

Tyson has over 10 years industry experience with Zebrafish, rodents and large animals and is currently Head of Bioresources at Centenary Institute. Tyson is on an executive committee member for the Australian…

Dr Sharma manages the research grants portfolio at the Centenary, helping our researchers apply for funding and manage their research programs. . Elipsha has experience as a quality control chemist…

For almost 20 years Pete has held numerous senior fundraising positions at the Sydney Children’s Hospital Network, Barnardos Australia and as Development Manager, Student Life, Sports and Entrepreneurship manager UNSW.…

Dr Dannel Yeo is an emerging expert in translational cancer research and precision medicine who leads the Precision Oncology Laboratory at Centenary Institute.. He has led efforts to understand cancer drivers in patients…